Figures
- Fig. 1—
Robert Koch (1843–1910), who discovered Mycobacterium tuberculosis in 1882. Nobel Laureate Physiology or Medicine, 1905.
- Fig. 2—
The title page of Robert Koch's original article published in Berliner Klinische Wochenschrift on April 10, 1882 1. This journal is no longer in existence. Provided courtesy of H.L. Rieder (Tuberculosis Division, International Union Against Tuberculosis and Lung Disease, Paris, France).
- Fig. 3—
The global prevalence of multidrug-resistant tuberculosis (MDR-TB) among new cases and the countries in which at least one case of extensively drug-resistant TB (XDR-TB) was described. MDR: cases resistant to at least rifampicin and isoniazid. XDR: resistance to at least rifampicin and isoniazid, in addition to any fluoroquinolone, and to at least one of the three following injectable drugs used in anti-TB treatment: capreomycin, kanamycin and amikacin. The following countries had at least one case of XDR-TB described: Argentina, Armenia, Bangaldesh, Brazil, Chile, Czech Republic, Ecuador, France (one case imported), Georgia, Germany, Italy, Republic of Korea, Latvia, Mexico, Peru, Portugal, Russian Federation, South Africa, Spain, Thailand, the UK and the USA. Figure reproduced from 4 with permission from the Stop TB Department, World Health Organization, Geneva, Switzerland.
